|
DJI136 Clinical Trials
1 actively recruiting trial across 1 location
Pipeline
Phase 1/2: 1
Top Sponsors
- Novartis Pharmaceuticals1
Indications
- Extensive Stage Small Cell Lung Cancer (ES-SCLC)1
- Lung Cancer1
- Cancer1
Houston, Texas1 trial
A Study to Evaluate DJI136, a DLL3-targeted CAR-T Therapy
MD Anderson Cancer Center
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.